Clinical Trials Logo

Metabolic Diseases clinical trials

View clinical trials related to Metabolic Diseases.

Filter by:

NCT ID: NCT03317873 Completed - Clinical trials for Iron Metabolism Disorders

The Effect of Genetic Variation in TMPRSS6 Gene (SNP rs855791) on Oral Iron Absorption: an Iron Stable Isotope Study

Start date: November 1, 2017
Phase: N/A
Study type: Interventional

Iron deficiency is considered the most common nutritional deficiency worldwide and affects children and women in both non-industrialized as well as industrialized countries. The main regulatory molecule of iron metabolism is hepcidin, a hormone produced in the liver that regulates intestinal iron absorption, placental transport, recycling of iron by macrophages and release from stores. The expression of hepcidin is regulated by many mediators, one of which is Matriptase-2 - a transmembrane protease. Complete loss of function leads to the rare disease iron-refractory iron deficiency anemia (IRIDA). Matriptase-2 is encoded by the gene TMPRSS6 and the single nucleotide polymorphism (SNP) rs855791 causes a non-synonymous substitution (V736A) that reduces the activity of the protease to inhibit hepcidin transcription. Genome wide association studies have identified the TMPRSS6 SNP rs855791 has a strong association with red blood cell and iron parameters in the general population. The objectives of the study is to measure oral iron absorption and systemic iron utilization into red blood cells (RBC) using oral isotopic labels in subjects homozygotes for common variants of the TMPRSS6 gene with the SNP rs855791 (A736V); AA vs. VV subjects. The aim is to conduct an iron absorption study in 80 Taiwanese women of reproductive age, non-pregnant, non-anemic, investigating the effect of the genetic variants of the SNP rs855791. The participants will be split in two groups of equal size; wild type AA vs. mutation VV. Iron absorption and systemic utilization will be assessed by two test meals containing stable isotopes of iron.The primary outcome of the trial is the oral iron absorption from a test meal as compared between the two genotypes AA vs. VV. Secondary outcomes are the comparison iron status markers between the two genotypes.

NCT ID: NCT03314714 Completed - Clinical trials for Lipid Metabolism Disorders

Duality of Lipids: the Athlete's Paradox

LIDDIA
Start date: April 3, 2017
Phase: N/A
Study type: Interventional

Accumulation of intramyocellular lipids (IMCLs) due to increased supply of fatty acids can induce defects in the insulin signaling cascade, causing skeletal muscle insulin resistance. However, the causes for muscle insulin resistance are not well understood. The association of elevated IMCLs and insulin resistance has been shown in obese humans and individuals with type 2 diabetes as well as several animal models of insulin resistance. Despite the strong relationship between IMCLs and insulin resistance, this suggested relationship disappears when well-trained endurance athletes are included into this consideration as this group is highly insulin sensitive. This metabolic enigma has been termed the 'athlete's paradox'. The aim of this project is to resolve the mechanisms contributing to the athlete's paradox.

NCT ID: NCT03314506 Completed - Metabolic Disease Clinical Trials

Adipose Tissue Cellular Response to Exercise in Healthy Humans

FLOW
Start date: November 1, 2017
Phase: N/A
Study type: Interventional

The purpose of this study is to measure the effects of a single session of exercise on changes in the cellular composition of the body fat of humans.

NCT ID: NCT03313869 Completed - Oxidative Stress Clinical Trials

A Nutrient Cocktail to Protect Against Physical Inactivity

Start date: June 2015
Phase: N/A
Study type: Interventional

This experiment consists on a 20-day reduction in daily step in free-living active individuals to induce physical inactivity. This will be used to test the efficacy of the anti-oxidant cocktail we aim to test as a new countermeasure in 2016 during the 60-d bed rest planed by ESA/CNES. The objective of this study is to investigate whether the cocktail of natural antioxidants XXS-2A comprising vitamin E and coupled with omega-3 helps to prevent and / or reduce the glucose intolerance and improve oxidative defenses induced by 20 days of physical inactivity through daily step reduction Although physical inactivity is reported to affect glucose tolerance within days of inactivity, we selected a period of 20 days for the effect of the cocktail to take place and assess secondary molecular mechanisms. The effect of this short period of inactivity on metabolism will moreover be boosted during the last 10 days by taking fructose, a sugar found in abundance in fruits, honey and juices, which is known to quickly trigger metabolic deregulation.

NCT ID: NCT03305783 Completed - Clinical trials for Glucose Metabolism Disorders

The Influence of Cholecystectomy on Secretion of Incretin Hormones

Start date: November 1, 2017
Phase:
Study type: Observational

The effect of cholecystectomy on postprandial plasma GLP-1 responses (primary endpoint) and glucose metabolism will be evaluated in 30 patients planned to undergo elective laparoscopic cholecystectomy.

NCT ID: NCT03301948 Completed - Metabolic Disease Clinical Trials

Effects of a Single Day of Mixed Macronutrient Overfeeding on Energy Balance and Metabolic Responses

Start date: May 1, 2017
Phase: N/A
Study type: Interventional

Healthy male participants are recruited to observe potentially deleterious changes in appetite regulation and metabolic control. Participants will be provided with an energy intake representative of their daily requirements on the first day of one trial and will be provided with an additional 50% energy intake on the first day of another trial. Outcome variables will be assessed during the second day of each trial in response to a fixed mixed macronutrient meal tolerance test.

NCT ID: NCT03284216 Completed - Hyperglycemia Clinical Trials

Hyperglycemia and Exercise.

GlucotoxEx
Start date: August 1, 2017
Phase: N/A
Study type: Interventional

This study will determine whether exposure to short-term high blood glucose levels impairs exercise-induced adaptations in glucose tolerance, and whether the pattern of high blood glucose levels plays a role.

NCT ID: NCT03276247 Completed - Clinical trials for Iron Metabolism Disorders

Iron Status in Women of Reproductive Age Reproductive Age

Start date: January 1, 2016
Phase: N/A
Study type: Observational

Analyzed iron status, HFE mutations and ethnicity for women in five primary care centers in the United States and Canada using de-identified data from the HEIRS study.

NCT ID: NCT03275948 Completed - Clinical trials for Metabolic Disorders and Cognitive Decline

Effects of Whole Grain Rye on Metabolic Risk Markers and Mood

Start date: November 1, 2016
Phase: N/A
Study type: Interventional

The purpose of the study is to investigate, in healthy middle age subjects, effects of whole grain rye on cognitive functions, mood, and cardiovasculair risk markers

NCT ID: NCT03272646 Completed - Clinical trials for Nutritional and Metabolic Diseases

Prognostic Performance of the Naples Prognostic Score

NPS
Start date: January 1, 2000
Phase: N/A
Study type: Observational [Patient Registry]

To investigate the prognostic performance of the Naples Prognostic Score in gastric cancer patients undergoing surgery